The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control
- PMID: 10411902
- PMCID: PMC17543
- DOI: 10.1073/pnas.96.15.8489
The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control
Abstract
Alteration of the FHIT (fragile histidine triad) gene occurs as an early and frequent event in lung carcinogenesis. FHIT gene transfer into lung cancer cell line H460 lacking Fhit protein expression resulted in reversion of tumorigenicity. To gain insight into the biological function of FHIT, we compared the H460 cell line with its Fhit transfectants (H460/FHIT). A significant inhibition of cell growth was observed in H460/FHIT cells. The analysis of apoptosis by in situ terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling revealed a high rate of apoptosis-induced DNA strand breaks in stable clones. In situ results were confirmed by FACScan analysis that showed an apoptotic rate of 44-47% compared with a 15% level in the control H460 cells. Analysis of cell cycle-phase distribution indicated a significant G(0)/G(1) arrest and the presence of a sub-G(1) peak in the stable clones. No significant changes in Bcl2, BclX, and Bax protein expression level were observed in the transfected clones as compared with the control H460 cells whereas a 2-fold increase in Bak protein levels was noticed. An increased level of p21(waf) protein paralleled by an up-regulation of p21(waf) transcripts also was found in Fhit-expressing clones compared with the H460 cell line. No differences in p53 levels were observed in the same cells, suggesting a p53-independent effect. These data suggest that the observed growth-inhibitory effect in FHIT-reexpressing cells could be related to apoptosis and cell cycle arrest and link the tumor-suppressor activity of FHIT to its proapoptotic function.
Figures





Similar articles
-
Effect of FHIT gene replacement on growth, cell cycle and apoptosis in pancreatic cancer cells.Pancreatology. 2003;3(4):293-302. doi: 10.1159/000071767. Pancreatology. 2003. PMID: 12890991
-
The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.Oncogene. 2004 Dec 2;23(56):9102-10. doi: 10.1038/sj.onc.1208142. Oncogene. 2004. PMID: 15489891
-
Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.Mol Med. 2001 Jul;7(7):442-53. Mol Med. 2001. PMID: 11683369 Free PMC article.
-
[FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].Postepy Biochem. 2009;55(1):66-75. Postepy Biochem. 2009. PMID: 19514467 Review. Polish.
-
Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.JAMA. 2001 Nov 21;286(19):2441-9. doi: 10.1001/jama.286.19.2441. JAMA. 2001. PMID: 11712940 Review.
Cited by
-
NIT1 suppresses tumour proliferation by activating the TGFβ1-Smad2/3 signalling pathway in colorectal cancer.Cell Death Dis. 2018 Feb 15;9(3):263. doi: 10.1038/s41419-018-0333-3. Cell Death Dis. 2018. PMID: 29449642 Free PMC article.
-
A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence.Genome Biol. 2016 Dec 16;17(1):261. doi: 10.1186/s13059-016-1114-x. Genome Biol. 2016. PMID: 27986087 Free PMC article.
-
The nitrilase superfamily: classification, structure and function.Genome Biol. 2001;2(1):REVIEWS0001. doi: 10.1186/gb-2001-2-1-reviews0001. Epub 2001 Jan 15. Genome Biol. 2001. PMID: 11380987 Free PMC article. Review.
-
Methylation status of the FHIT gene in the transformed human mesenchymal F6 stem cell line.Oncol Lett. 2015 Jun;9(6):2661-2666. doi: 10.3892/ol.2015.3092. Epub 2015 Apr 1. Oncol Lett. 2015. PMID: 26137124 Free PMC article.
-
Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.Br J Cancer. 2004 Jun 14;90(12):2378-83. doi: 10.1038/sj.bjc.6601778. Br J Cancer. 2004. PMID: 15150628 Free PMC article.
References
-
- Ohta M, Inoue H, Cotticelli M G, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, et al. Cell. 1996;84:587–597. - PubMed
-
- Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese M L, et al. Cancer Res. 1997;57:5207–5212. - PubMed
-
- Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti M A, et al. Cancer Res. 1998;58:5032–5037. - PubMed
-
- Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue P A, Pekarsky Y, Ohta M, Huebner K, Lubinski J. Cancer Res. 1998;58:2946–2951. - PubMed
-
- Greenspan D L, Connolly D C, Wu R, Lei R Y, Vogelstein T C, Kim Y T, Mok J E, Munoz N, Bosch X, Shah K, et al. Cancer Res. 1997;57:4692–4698. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous